Paper - WANFANG MED ONLINE

You Position: Home > Paper

National consensus for the treatment of Helicobacter pylori and related symptoms base on integrative traditional Chinese and western medicine

( views:161, downloads:253 )

Author:: No author available

Journal Title:: Chinese Journal of Health Management

Issue:: 5

DOI:: 10.3760/cma.j.issn.1674-0815.2018.05.003

Key Word:: No keyword available

Abstract：幽门螺杆菌与慢性胃炎、消化性溃疡、胃癌及胃黏膜相关淋巴组织淋巴瘤的发生发展密切相关.1994年幽门螺杆菌被世界卫生组织列为胃癌发生的Ⅰ类致癌因子,胃癌发生与幽门螺杆菌感染密切相关,根除幽门螺杆菌可降低胃癌的发生率.中国是幽门螺杆菌高感染率国家,同时也是胃癌高发国家,幽门螺杆菌感染不仅是一个临床问题,更是一个公共卫生层面的健康管理大问题,因此本共识对我国幽门螺菌相关疾病防治具有重大现实意义.

Reference

[1]查安生,石美雅,章小平,等.健胃冲剂联合西药对幽门螺杆菌初次根除失败后的疗效影响[J].2006,(5).
[2]胡伏莲.幽门螺杆菌根除失败的原因分析和处理策略[J].2010,(2).
[3]王同单.加味泻心颗粒治疗脾胃湿热型Hp相关性非萎缩性胃炎的临床研究[D].2015.
[4]胡伏莲.论幽门螺杆菌感染的“共识”意见与“个性化治疗”[J].2016,(4).
[5]成虹,胡伏莲,盛剑秋,等.荆花胃康胶丸联合含呋喃唑酮三联或四联疗法补救治疗幽门螺杆菌感染的多中心随机对照研究[J].2016,(40).
[6]胡伏莲,成虹,张学智,等.多中心临床观察荆花胃康联合三联疗法治疗幽门螺杆菌相关性十二指肠溃疡和胃炎疗效及耐药分析[J].2012,(10).
[7]方洒,盛剑秋,金鹏,等.标准三联及经典四联方案联合铝碳酸镁对部队官兵根除幽门螺杆菌的疗效研究[J].2017,(6).
[8]李玉红.乳香胶抗幽门螺杆菌成份活性评价与作用机理研究[D].2007.
[9]韩玉山,杨强,王东旭,等.荆花胃康三联疗法治疗幽门螺杆菌阳性慢性胃炎临床疗效的多中心随机双盲临床研究[J].2011,(31).
[10]牟方宏,胡伏莲,杨桂彬.温胃舒、养胃舒预防幽门螺杆菌培养上清液所致小鼠胃黏膜损伤[J].2007,(13).
[11]关春峰,袁志荣.中药合四联疗法治疗幽门螺旋杆菌相关性胃溃疡观察[J].2008,(2).
[12]中华医学会消化病学分会幽门螺杆菌和消化性溃疡学组,全国幽门螺杆菌研究协作组,刘文忠,等.第五次全国幽门螺杆菌感染处理共识报告[J].2017,(7).
[13]刘志为.四联疗法联合中医药对幽门螺杆菌的补救治疗[J].2012,(8).
[14]胡玢婕,赵付菊,赵虎.幽门螺杆菌生物膜形成与其耐药机制的相关性[J].2014,(8).
[15]Rachel O'Mahony,Huda Al-Khtheeri,Deepeka Weerasekera,etc.Bactericidal and anti-adhesive properties of culinary and medicinal plants against Helicobacter pylori[J].2005,(47).
[16]胡伏莲.幽门螺杆菌感染治疗现状与展望[J].2012,(8).
[17]王冬.中药三仁汤联合"四联疗法"治疗幽门螺杆菌感染的疗效分析[J].2015,(8).
[18]JIANG Lin,Wei-Wen Huang.A systematic review of treating Helicobacter pylori infection with Traditional Chinese Medicine[J].2009,(37).
[19]刘文忠.《幽门螺杆菌感染的处理：Maastricht Ⅴ/Florence 共识报告》解读[J].2016,(10).
[20]黄衍强,黄干荣,李晓华,等.中药提取物对耐药幽门螺杆菌生物膜形成的影响[J].2013,(11).
[21]李江,成虹,高文,等.不同中药提取物对幽门螺杆菌耐药菌株体外抗菌活性研究[J].2015,(2).
[22]陈世耀,高虹,李锋,等.三联方案联合温胃舒或养胃舒根除幽门螺杆菌治疗胃溃疡疗效评价[J].2011,(2).
[23]董欣红,胡伏莲,李世荣,等.三九胃泰四联疗法治疗消化性溃疡及根除幽门螺杆菌的多中心临床研究[J].2002,(6).
[24]张月苗,王婷婷,叶晖,等.荆花胃康胶丸联合三联疗法治疗幽门螺杆菌感染慢性胃炎疗效观察[J].2013,(11).
[25]莫莉,皮明钧,伍参荣,等.半夏泻心汤及其拆方对幽门螺杆菌感染小鼠胃黏膜CD4、CD8表达的影响[J].2006,(1).
[26]胡伏莲.重视幽门螺杆菌感染根除治疗中的几个问题[J].2013,(44).
[27]崔梅花,魏红,雷晓燕,等.含复方尿囊素四联疗法治疗幽门螺杆菌感染慢性胃炎的疗效[J].2014,(5).
[28]刘绍能,刘正新,孟淼,等.摩罗丹配合雷贝拉唑三联疗法治疗幽门螺杆菌相关慢性胃炎疗效观察[J].2017,(7).
[29]李玉锋,张晓军,姜巍,等.中药联合三联疗法与三联疗法对照治疗幽门螺杆菌相关性胃部疾病随机对照试验的Meta分析[J].2014,(2).
[30]"温胃舒或养胃舒治疗幽门螺杆菌相关性慢性胃炎和消化性溃疡"全国多中心临床研究科研协作组.温胃舒或养胃舒治疗幽门螺杆菌相关性慢性胃炎和消化性溃疡的全国多中心临床研究[J].2010,(2).
[31]胡伏莲.难治性幽门螺杆菌感染处理原则和策略[J].2017,(10).
[32]胡伏莲.幽门螺杆菌感染治疗的新路径[J].2012,(10).
[33]Theresa Wan-Chen, Yap,Han-Ming, Gan,Yin-Peng, Lee,etc.Helicobacter pylori Eradication Causes Perturbation of the Human Gut Microbiome in Young Adults.[J].2016.
[34]A, Bühling,D, Radun,W A, Müller,etc.Influence of anti-Helicobacter triple-therapy with metronidazole, omeprazole and clarithromycin on intestinal microflora.[J].2001,15(9).
[35]汪楠,王垂杰,李玉锋.中药联合“四联疗法”治疗Hp阳性慢性胃炎疗效观察[J].2017,(4).
[36]Yi, Hu,Yin, Zhu,Nong-Hua, Lu.Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance.[J].2017,7(Spec ).
[37]Vincenzo, De Francesco,Floriana, Giorgio,Cesare, Hassan,etc.Worldwide H. pylori antibiotic resistance: a systematic review.[J].2010,19(4).
[38]李淑红,刘华一,唐艳萍.香砂六君子汤联合四联疗法治疗幽门螺杆菌感染致脾胃虚弱型消化性溃疡48例临床观察[J].2016,(21).
[39]Enzo Ierardi,Floriana Giorgio,Giuseppe Losurdo,etc.How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?[J].2013,(45).
[40]Wei, Liu,Yu, Liu,Xue-Zhi, Zhang,etc.In vitro bactericidal activity of Jinghua Weikang Capsule and its individual herb Chenopodium ambrosioides L. against antibiotic-resistant Helicobacter pylori.[J].2013,19(1).
[41]Malfertheiner, P.,Megraud, F.,O'Morain, C. A.,etc.Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report[J].2017,66(1).
[42]Kita M,Yamamoto T,Kuriyama H,etc.Antibacterial effect of Kampo herbal formulation Hochu-ekki-to (Bu-Zhong-Yi-Qi-Tang) on Helicobacter pylori infection in mice[J].2002,46(7).
[43]Vasilios Papastergiou,Sotirios D Georgopoulos,Stylianos Karatapanis.Treatment of Helicobacter pylori infection:Meeting the challenge of antimicrobial resistance[J].2014,(29).
[44]潘涛,顾兴平,刘芙成,等.加味左金丸在幽门螺杆菌根除失败后补救治疗中的疗效评价[J].2014,(7).
[45]Min-min ZHANG,Wei Qian,Ying-Yi Qin,etc.Probiotics in Helicobacter pylori eradication therapy: A systematic review and meta-analysis[J].2015,(14).
[46]Li, J.,Xu, L.,Cheng, H.,etc.The evolution of Helicobacter pylori antibiotics resistance over 10 years in Beijing, China[J].2010,15(5).
[47]Yue-Feng Tong,Jun Lv,Li-Yuan Ying,etc.Seven-day triple therapy is a better choice for Helicobacter pylori eradication in regions with low antibiotic resistance[J].2015,(46).
[48]Kotilea, Kallirroi,Mekhael, Joyce,Salame, Assaad,etc.Eradication rate of Helicobacter Pylori infection is directly influenced by adherence to therapy in children[J].2017,22(4).
[49]Jones, Nicola L.,Koletzko, Sibylle,Goodman, Karen,etc.Joint ESPGHAN/NASPGHAN Guidelines for the Management of Helicobacter pylori in Children and Adolescents (Update 2016)[J].2017,64(6).
[50]EM El-Omar,K Oien,A El-Nujumi,etc.Helicobacter pylori infection and chronic gastric acid hyposecretion[J].1997,113(1).
[51]Qin-Juan Sun,XIAO Liang,Qing Zheng,etc.Resistance of Helicobacter pylori to antibiotics from 2000 to 2009 in Shanghai[J].2010,(40).
[52]Bartlett, John G..Antibiotic-Associated Diarrhea.[J].2002,346(5).
[53]Tian Zou,Jie Dong,Xiaofeng Yu.Meta-Analysis: Lactobacillus Containing Quadruple TherapyVersus Standard Triple First-Line Therapy for Helicobacter pyloriEradication[J].2009,14(5).
[54]洪海洲,刘天易.加味三仁汤对慢性胃炎首次根除幽门螺杆菌失败后的治疗[J].2015,(23).
[55]Nauta, A.,Schols, H. A.,Schuren, F. H. J.,etc.High-throughput analysis of the impact of antibiotics on the human intestinal microbiota composition[J].2013,92(3).
[56]蔡锐,肖新云,尹抗抗,等.戊己丸对幽门螺杆菌感染胃炎小鼠胃内微生物及酶的影响[J].2015,(3).
[57]Hu, Yi,Zhu, Yin,Lu, Nong-hua.Primary Antibiotic Resistance of Helicobacter pylori in China[J].2017,62(5).
[58]Tan, Bei,Luo, Han-Qing,Xu, Hong,etc.Polaprezinc combined with clarithromycin-based triple therapy for Helicobacter pylori-associated gastritis: A prospective, multicenter, randomized clinical trial.[J].2017,12(4).
[59]邓天好,谭达全,龙承星,等.半夏泻心汤治疗幽门螺杆菌相关性胃炎与消化性溃疡的Meta分析[J].2015,(10).
[60]澹台新兴,杨龙宝,卜翔,等.荆花胃康联合PPI三联疗法治疗幽门螺杆菌相关慢性胃炎或消化性溃疡有效性和安全性的Meta分析[J].2017,(2).
[61]Li, Lei,Meng, FanDong,Zhu, Shengtao,etc.Efficacy and Safety of Wei Bi Mei, a Chinese Herb Compound, as an Alternative to Bismuth for Eradication of Helicobacter pylori.[J].2018.
[62]唐燕锋,邵君,俞庆宪.胃复春胶囊联合四联疗法治疗幽门螺杆菌感染慢性胃炎70例[J].2017,(10).
[63].Randomized Double-Blind Clinical Trial of Moluodan（摩罗丹） for the Treatment of Chronic Atrophic Gastritis with Dysplasia[J].2016,22(1).
[64]B, Citterio,A, Casaroli,L, Pierfelici,etc.Morphological changes and outer membrane protein patterns in Helicobacter pylori during conversion from bacillary to coccoid form.[J].2004,27(4).
[65]马继征,冯硕,胡伏莲.分阶段综合治疗难治性幽门螺杆菌感染63例临床观察[J].2018,(1).
[66]Chiba, Naoki,Gisbert, Javier P.,Jones, Nicola L.,etc.The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults[J].2016,151(1).
[67]Hu, Yue,Zhang, Meng,Lu, Bin,etc.Helicobacter pylori and Antibiotic Resistance, A Continuing and Intractable Problem[J].2016,21(5).
[68]Sugano, Kentaro,Tack, Jan,Kuipers, Ernst J.,etc.Kyoto global consensus report on Helicobacter pylori gastritis[J].2015,64(9).
[69]Shuang Liu,Zhifang Liu,Chunyan Chen,etc.The antibacterialmode ofaction of allitridi for its potential use as a therapeutic agent againstHelicobacter pylori infection[J].2010,303(2).
[70]Bao-Zhu, Li,Diane Erin, Threapleton,Ji-Yao, Wang,etc.Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis.[J].2015,351.
[71]李玉锋,姜巍,王垂杰,等.中药与三联疗法对照治疗幽门螺杆菌相关性胃部疾病随机对照试验Meta分析[J].2014,(2).